Illumina's Moleculo Provides Long DNA Fragment Sequences to Improve Genomes, Clinical Assays
January 15, 2013
By Julia Karow
This article, originally published Jan. 14, has been updated with additional information from Illumina.
A week after Illumina acquired San Francisco-based startup Moleculo for an undisclosed amount, some early-access customers spoke about their experience with the firm's long fragment sequences for the assembly of complex genomes.
Moleculo, which has developed a technology to break genomic DNA into large pieces, sequence them with short reads, and assemble these into so-called "long reads," said it sees applications in the de novo assembly of plant and other complex genomes, human genome sequencing, and cancer sequencing.
****EDITED FOR PAID CONTENT****
Please see here for the full article: http://www.genomeweb.com/sequencing/...nomes-clinical
January 15, 2013
By Julia Karow
This article, originally published Jan. 14, has been updated with additional information from Illumina.
A week after Illumina acquired San Francisco-based startup Moleculo for an undisclosed amount, some early-access customers spoke about their experience with the firm's long fragment sequences for the assembly of complex genomes.
Moleculo, which has developed a technology to break genomic DNA into large pieces, sequence them with short reads, and assemble these into so-called "long reads," said it sees applications in the de novo assembly of plant and other complex genomes, human genome sequencing, and cancer sequencing.
****EDITED FOR PAID CONTENT****
Please see here for the full article: http://www.genomeweb.com/sequencing/...nomes-clinical
Comment